Skip to main content

Table 2 Study outcomes in the two treatment groups

From: Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study

  No myo-inositol Yes myo-inositol p
Group A Group B
N = 50 N = 50
No. oocytes retrieved/patient 7.6 ± 3.8 5.9 ± 2.4 <0.01
Mean ± SD
No. metaphase II/patient 6.3 ± 2.9 4.8 ± 2.2 <0.05
Mean ± SD    
No. inseminated eggs/patient 6 ± 2.7 4.8 ± 2.2 (240) <0.05
Mean ± SD    
No. 2PN oocytes/patient 4.3 ± 2.3 3.3 ± 1.8/163 <0.01
Mean ± SD  
Fertilization rate (2PN/inseminated oocytes) 70.8 ± 20.4 68.4 ± 19.2 0.7
(%) ± SD    
No. Embryos/patient 3.58 ± 2.1 2.5 ± 1 .1 <0.001
Mean ± SD    
Cleavage rate (embryos/2PN oocytes) 82.2 ± 29.9 84.5 ± 28.7 0.7
(%) ± SD    
No. embryos Grade I and II : number 173 (96.6%) 117 (93.6%) 0.2
and percentage of total    
No. of patients receiving 1 47 (94%) 1
embryos (%)    
No. of embryos transferred per 2.4 ± 1 2.2 ± 0.8 0.39
starting patients Mean ± SD    
No. Clinical pregnancies 12/47 (25.5%) 14/47 (29.8%) 0.52
No. of fetal hearts 16 (13.3%) 21 (18.7%) 0.08
(implantation rate)